APA (7th ed.) Citation

Bengueddache, S., Cook, M., Lehmann, S., Arroyo, D., Togni, M., Puricel, S., & Cook, S. (2024). Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds--insights from the EVERBIO-2 trial. Frontiers in cardiovascular medicine, 01. https://doi.org/10.3389/fcvm.2024.1426348

Chicago Style (17th ed.) Citation

Bengueddache, Samir, Malica Cook, Sonja Lehmann, Diego Arroyo, Mario Togni, Serban Puricel, and Stephane Cook. "Ten-year Clinical Outcomes of Everolimus- and Biolimus-eluting Coronary Stents Vs. Everolimus-eluting Bioresorbable Vascular Scaffolds--insights from the EVERBIO-2 Trial." Frontiers in Cardiovascular Medicine 2024: 01. https://doi.org/10.3389/fcvm.2024.1426348.

MLA (9th ed.) Citation

Bengueddache, Samir, et al. "Ten-year Clinical Outcomes of Everolimus- and Biolimus-eluting Coronary Stents Vs. Everolimus-eluting Bioresorbable Vascular Scaffolds--insights from the EVERBIO-2 Trial." Frontiers in Cardiovascular Medicine, 2024, p. 01, https://doi.org/10.3389/fcvm.2024.1426348.